ABBREVIATIONS: AP, acute pancreatitis; AT 1 receptor: angiotensin II type 1 receptor; CBPD, common biliopancreatic duct; CREB, cAMP-responsive element binding protein; DHE: dihydroethidium; ERK, extracellular-regulated kinase; IL-6, interleukin-6; Losartan, Obstruction of common bilio-pancreatic duct time-dependently enhanced angiotensinogen levels, which correlated well with superoxide generation, ERK1/2 and CREB phosphrylation and subsequent IL-6 expression. More importantly, changes in these parameters were antagonized by prophylactic administration of losartan. These in vitro and in vivo results indicate that angiotensin II induces redox-regulated ERK1/2 and CREB This article has not been copyedited and formatted. The final version may differ from this version.
Introduction
Interleukin 6 (IL-6) is a multi-functional and pro-inflammatory cytokine that regulates the progression of self-limiting acute pancreatitis (AP) to the systemic inflammation. Patients with AP exhibit elevated serum IL-6 levels within 48 hours following the onset of symptoms, and these levels correlate well with disease severity (Davies and Hagen, 1997) . Neutralization of IL-6 using monoclonal antibody has been demonstrated to attenuate experimental AP and its associated pulmonary injury (Chao et al., 2006) . In this regard, pharmacological antagonism of IL-6 action is suggested to serve as one of targets for the management of pancreatitis.
Emerging body of evidence has shown that local pancreatic renin-angiotensin system (RAS) plays a crucial role in the pathophysiology of AP. Pancreatic expression of the major components of RAS were upregulated in experimental AP . The non-specific angiotensin II receptor blocker, saralasin, inhibited the onset of pancreatitis and oxidative stress . The specific antagonist of AT 1 receptor, losartan, also ameliorated the pancreatic injury initiated by hyperstimulation with caerulein (Tsang et al., 2004 b) . The protective effects of losartan are not only restricted to local pancreatic levels but also extended to AP-induced systemic inflammation (Chan and Leung, 2006) . This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on February 11, 2009 as DOI: 10.1124 at ASPET Journals on April 2, 2017 jpet.aspetjournals.org Downloaded from JPET #148353 6 Recently, we have reported that angiotensin II, via the AT 1 receptor, exerts oxidative stress to activate nuclear factor kappa B (NFκB) during experimental pancreatitis . However, it is well documented that reactive oxygen species (ROS) not only switch on NFκB but also trigger the activation of redox-sensitive mitogen-activated protein kinase (MAPK) in a variety of cell types.
MAPKs, in particular extracellular-regulated kinase (ERK) 1/2, are responsive to such stimuli as cytokines, growth factors, ROS and cellular stress, which ultimately regulate multiple cellular processes including cytoskeleton arrangement, transcription factor activation, apoptosis, proliferation and differentiation (Leung and Chan, 2009 ). In isolated pancreatic acini, H 2 O 2 and menadione, a strong superoxide generator, trigger ERK1/2 activation that is comparable to that induced by CCK (Dabrowski et al., 2000) .
Angiotensin II, via ROS generation, triggers activation of ERK1/2 in renal proximal tubule cells (Tanifuji et al., 2005) , vascular smooth muscle cells (Viedt et al., 2000; Kranzhofer et al., 1999) , and neutrophils (El Bekay et al., 2003) . Which particular cell type contributes to the redox-sensitive pathways during AP pathogenesis, however, remains ambiguous. In this study, we employed in vivo and in vitro systems to demonstrate the involvement of ERK1/2 in regulating angiotensin II-induced IL-6 expression in pancreatic acinar cells during pancreatic inflammation.
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Methods
In Vitro Studies. AR42J cell line (ATCC, VA, USA), which is a rat pancreatic cell line derived from exocrine pancreas of Wistar rat, was employed in the present study. They were cultured in Kaighn's modification of Ham's F12 medium (F12K) (Invitrogen) with the supplement of 20% fetal bovine serum (Invitrogen) and antibiotics (100U/ml penicillin and 100μg/ml streptomycin) (Invitrogen). The cells were treated with exogenous angiotensin II (Tocris) at different concentration and time. Losartan (Merck Research Laboratory), PD123319 (Sigma), and N-acetyl cysteine (Sigma) were dissolved in phosphate buffered saline (PBS) and incubated with the cells 10 minutes prior to treatment. PD98059 (Sigma) was dissolved in dimethyl sulfoxide (DMSO) (Sigma) and they were pre-treated for 30 minutes prior to peptide stimulation. After treatment, the cells were rinsed with PBS and lyzed with lysis buffer to collect protein. For dihydroethidium (DHE) (Sigma) staining, the cells were immediately fixed with fixative and then subjected to staining. JPET #148353 8 standardized rat chow, but were fasted for 24 to 28 hrs prior to being subjected to the experiments. Obstructive pancreatitis, mimicking gallstone obstruction-induced AP, was induced by ligation of common biliopancreatic duct (CBPD) as described previously Chan and Leung, 2007 b) . Briefly, the animal (250-300g) underwent laparotomy and the CBPD was double-ligated. For losartan treatment group, rats were given 30mg/kg losartan, an AT 1 receptor antagonist, intragastrically one hour before surgery. The animals were killed six hours after surgery. The Pancreas was isolated and snapped frozen for further analysis. Tissues for immunohistochemistry processing were isolated, fixed in 4% paraformaldehyde (PFA) (ICN) in PBS, and embedded in paraffin for sectioning. For cryosection (DHE-staining), the tissues were quickly Western Blot Analysis. Pancreatic protein was extracted for SDS-PAGE and subsequent blotted onto a PVDF membrane as described previously .
In Vivo
Antibodies against IL-6 (Santa Cruz, 1:1000), phospho-ERK (Cell Signaling, 1:1000), or phospho-CREB (Cell Signaling, 1:500) were incubated with the membrane overnight at 4°C.
β -actin (Abcam, 1:4000) was used as an internal control for IL-6. For phospho-MAPK and phospho-CREB, the membranes were stripped and probed with Immunocytohistochemistry and dihydroethidium (DHE) staining. Paraffin embedded tissues were sectioned, de-waxed, re-hydrated and blocked as described in previous study . The slides were incubated with goat anti-IL-6 (Santa Cruz, RNA extraction, reverse transcription and real-time PCR. Pancreatic RNA was extracted by TRIzol reagent (Invitrogen) as described previously (Wong et al., 2007) .
Reverse transcription (RT) was performed using SuperscriptTM First-Strand Synthesis System (Invitrogen) as described by the kit. Semi-quantification of mRNA was achieved Figure 1D ). Continuous treatment also yielded elevated ERK activation but it is not statistically-significant compared with control ( Figure 1D ).
Pretreatment of losartan, a specific AT 1 receptor blocker (0.5 and 5μM) did not exert any significant effects on ERK1/2 activation after stimulation of angiotensin II for 5 mins, representing 20% and 8.7% decrease respectively. However, the protective effect was observed when 50μM of losartan was given, exerting a 57% reduction (Figure 2A ).
The reversal effect on ERK activation was confirmed by pre-treatment of ERK inhibitor PD98059. Pre-treatment of PD98059 at 5μM, but not 0.05 and 0.5μM, revealed a significant reversal effects on ERK activation (by nearly 70% reduction) ( Figure 2B ).
Similarly, pre-treatment of 50μM losartan significantly abolished the angiotensin II-induced IL-6 protein expression by 45% ( Figure 2C ). Interestingly, angiotensin II-induced IL-6 expression was antagonized by PD98059 at 5μM concentration by 52%
This article has not been copyedited and formatted. The final version may differ from this version. Figure 6C ). Co-localization of IL-6 and amylase expression (green stain) confirmed that the expression of IL-6 originate from pancreatic acinar cells during obstructive AP (orange stain in Figure 6C ).
This article has not been copyedited and formatted. The final version may differ from this version. pancreatitis (Leung and Chan, 2009 ). Concomitantly, angiotensin II has been demonstrated to trigger oxidative stress in several pancreatic cells such as beta cells (Chipitsyna et al. 2007 ), pancreatic islets (Chu et al., 2007) and pancreatic stellate cells (Masamune et al., 2008) . These findings are consistent with our data indicating that angiotensin II, via the AT 1 receptor, could result in generation of superoxide in pancreatic acinar cells in vitro and in vivo during AP. In the present study, administration of the antioxidant NAC could reverse ERK1/2 activation, suggesting that ERK1/2 is subjected to be redox-regulated to express IL-6 in pancreatic acinar cells.
One of the potential sources of ROS triggered by angiotensin II stimulation might be NADPH oxidase. It has been shown that AR42J cells express the key components of NADPH oxidase, which are subjected to be regulated upon stimulus (Yu et al., 2005a; Yu et al., 2005b; Yu et al., 2007) . Preliminary data demonstrated that NADPH oxidase Nevertheless, the underlying mechanism of redox-regulated ERK1/2 during pancreatitis has yet to be elucidated. Oxidative stress could activate membrane bound receptors such as epidermal growth factor receptor and platelet-derived growth factor receptor in a ligand-independent manner, subsequently leading to activation of Ras and ERK1/2 (Knebel et al., 1996; Zhougang and Schnellmann, 2004) . Protein tyrosine kinase Src could also be stimulated by ROS (Lee and Esselman, 2002) , which in turn directly activate ERK in Ras-dependent manner (Servitja et al., 2003) . In addition, redox-activated Src kinase could trigger phsopholipase C gamma activation, resulting in the release of inositol triphosphate (IP 3 ) and diacylglycerol (DAG) (Banan et al., 2001) . Intracellular calcium is then mobilized and released, leading to ERK activation in calmodulin-dependent manner (Schmitt et al., 2004) . Elevated intracellular calcium also triggers protein kinase C activation, turning on the Raf pathway and thus results in ERK activation (Zou et al., 1996) . On the other hand, ERK could be redox-regulated by suppressing the phosphatase activity; indeed oxidative stress inhibited protein phosphatase, thus resulting in activation of ERK (Lee and Esselman, 2002) . In this regard, ERK1/2 might also be activated in a similar manner; however, the precise mechanism by which ROS switch on ERK1/2 in AP awaits further elucidation.
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ERK1/2 controls many downstream mediators for the transcription of gene expression.
Among them, cAMP-responsive element binding protein (CREB) is one of the candidates which is closely related to inflammatory response. It has been shown that the promoter of IL-6 contains a number of cAMP-responsive element (CRE) (Ichiki, 2006) . Target disruption of the CRE site of IL-6 promoter impairs stimulus-induced pro-inflammatory gene expression, indicating that CREB is critical in mediating inflammatory response (Ichiki, 2006; Sano et al. 2001) . Besides, angiotensin II has been shown to promote the phosphorylation of CREB at Ser 113 in an ERK1/2-dependent manner (Cammarota et al., 2001 ). Taken together, our in vitro and in vivo data are in line with those previous reports, describing that CREB may be involved in ERK1/2-dependent angiotensin II-induced IL-6 expression in pancreatic acinar cells.
Undoubtedly, the beneficial effects of losartan are due to the blockade of AT 1 receptor, and thus subsequent abolishment of downstream pro-inflammatory pathways.
However, it is possible that the protective effects might also be attributed by stimulation of AT 2 receptor, the well-characterized AT 1 -counteracting receptor which expresses in exocrine pancreas as well as AR42J cell line. From the results in Figure 3A Figure 3) , suggesting that AT 2 receptor, despite its abundance in expression, is not involved in attenuation of redox-sensitive ERK-signaling. Actually, previous study from our group showed that PD123319 administrated either prophylactically or therapeutically, exert an insignificant effect on caerulein-induced AP (Tsang et al., 2004b) .
It is worthwhile noting that the effective dose of angiotensin II used in vitro experiment is 1μM, which is far higher than normal circulating levels. Previous studies have shown that basal intra-pancreatic generation of angiotensin II in canine pancreas was substantially higher than that detected in peripheral blood (Chappell et al., 1991) .
Moreover, local pancreatic RAS is subjected to upregulation during AP; the expression of the precursor of angiotensin II, angiotensinogen, is significantly augmented by 3 folds during obstructive pancreatitis. On top of this, our previous report indicated that experimental pancreatitis results in 6-fold increase in local pancreatic ACE activity (Ip et al. 2003b) . Increase in both angiotensinogen and ACE activity will result in enhanced production of local angiotensin II levels. On the other hand, infiltration of inflammatory cells could also contribute to the local generation of angiotensin II during AP. It has been reported that neutrophil expresses cathepsin G on their membrane, which could actively convert angiotensinogen to angiotensin II (Tonnesen et al. 1982) . Neutrophil could also promote angiotensin II generation via activation of prorenin (Dzau et al. 1987 ). On top of that, inflammatory cells themselves have their own intrinsic RAS which could also enhance the pool of angiotensin II in the pancreas (Wintroub et al., 1981; Wintroub et al., 1984) . Nevertheless, there are still no substantial data available to justify that high amount of angiotensin II may exist within pancreatic tissues, particularly during the episode of AP.
It should be mentioned that pancreatic acinar cells are not the only cell population which contributes to the pro-inflammatory actions. Ample of studies have shown the involvement of other pancreatic cells during the inflammatory process. It has been demonstrated that pancreatic ductal cells express pro-fibrogenic proteins during obstructive pancreatitis (Fukumura et al., 2007) . Indeed, immunoreactivity of IL-6 has been detected in acinar cells, pancreatic islet cells and ducts cells during human pancreatitis (Jablonowska et al., 2008) . Experimental induction of AP leads to elevated expression of toll-like receptor (TLR) 4 in pancreatic ductal epithelium, vascular endothelium and islet, further complicating the inflammatory signals (Li et al., 2005) . 
